The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.
Level 5 - mechanism / opinion, no new human data
Animal research in developing cats with no human data.
What was done
Developing male and female cats (postnatal days 28–41) underwent 6 hours of baseline polysomnography followed by 6 hours of monocular deprivation to induce ocular dominance plasticity. Animals were then administered an intraperitoneal injection of triazolam (1–10 mg/kg), zolpidem (10 mg/kg), ramelteon (0.1–1 mg/kg), or vehicle control (DMSO) and allowed 8 hours of ad libitum sleep. Cortical plasticity was assessed using optical imaging of intrinsic cortical signals and single-unit electrophysiology.
What was found
Zolpidem reduced sleep-dependent cortical plasticity by approximately 50% as assessed with optical imaging of intrinsic cortical signals. Triazolam disrupted sleep architecture and EEG metrics more profoundly than zolpidem but had no effect on plasticity. Ramelteon minimally altered sleep and had no effect on ocular dominance plasticity. No exact numerical sample sizes or confidence intervals were provided in the abstract.
Why it matters
This study shows that hypnotic drugs maintaining relatively physiological sleep architecture on polysomnography can still impair sleep-dependent cortical plasticity depending on specific pharmacological mechanisms.
Limits
Findings are from an animal model (kittens during a specific critical period of visual development) and cannot be directly generalized to human sleep or adult brain plasticity. The abstract omits total sample size (n), variance metrics, and detailed electrophysiological numerical data.
Cited by
- partial Natural sleep strengthens monocular deprivation-induced visual cortex synaptic plasticity by approximately 100%, whereas Ambien-induced sleep causes a 50% unwiring of those connections.